Can response to treatment predict outcome in patients with metastatic pancreatic adenocarcinoma (MPAC)?

被引:0
|
作者
Jayavalsan, Shinoj Pattali
Schmidt, Shannon Leah
Durkal, Vipal
Ritch, Paul S.
Thomas, James P.
Erickson, Beth
Christians, Kathleen K.
Tsai, Susan
Evans, Douglas B.
George, Ben
机构
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Froedtert Hosp, Milwaukee, WI USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
443
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Can the sequence of chemotherapy regimens influence outcome in patients with metastatic pancreatic adenocarcinoma (MPAC)?
    Schmidt, Shannon Leah
    Durkal, Vipal
    Jayavalsan, Shinoj Pattali
    Ritch, Paul S.
    Thomas, James P.
    Erickson, Beth
    Christians, Kathleen K.
    Tsai, Susan
    Evans, Douglas B.
    George, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [2] Geographic variation in systemic treatment of metastatic pancreatic adenocarcinoma (mPAC) patients in real world across Europe
    Taieb, J.
    Carrato, A.
    AMellbring
    Prager, G.
    Melisi, D.
    Westphalen, B.
    Macarulla Mercade, T.
    D'Esquermes, N.
    Ferreras, A.
    De Jong, F.
    ANNALS OF ONCOLOGY, 2018, 29 : 100 - +
  • [3] Immune Response in Metastatic Regional Lymph Nodes from Pancreatic Adenocarcinoma may Predict Patient Outcome
    Nizri, E.
    Sternbach, N.
    Gerstenhaber, F.
    Lahat, G.
    Klausner, J.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S164 - S164
  • [4] CA 19-9 Response A Surrogate to Predict Survival in Patients With Metastatic Pancreatic Adenocarcinoma
    Diaz, Celso L.
    Cinar, Pelin
    Hwang, Jimmy
    Ko, Andrew H.
    Tempero, Margaret A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (12): : 898 - 902
  • [5] Macroscopic features predict outcome in patients with pancreatic ductal adenocarcinoma
    Hori, Shutaro
    Shimada, Kazuaki
    Ino, Yoshinori
    Oguro, Seiji
    Esaki, Minoru
    Nara, Satoshi
    Kishi, Yoji
    Kosuge, Tomoo
    Hattori, Yukinori
    Sukeda, Aoi
    Kitagawa, Yuko
    Kanai, Yae
    Hiraoka, Nobuyoshi
    VIRCHOWS ARCHIV, 2016, 469 (06) : 621 - 634
  • [6] Macroscopic features predict outcome in patients with pancreatic ductal adenocarcinoma
    Shutaro Hori
    Kazuaki Shimada
    Yoshinori Ino
    Seiji Oguro
    Minoru Esaki
    Satoshi Nara
    Yoji Kishi
    Tomoo Kosuge
    Yukinori Hattori
    Aoi Sukeda
    Yuko Kitagawa
    Yae Kanai
    Nobuyoshi Hiraoka
    Virchows Archiv, 2016, 469 : 621 - 634
  • [7] Circulating tumor cells as a surrogate for treatment response in patients with metastatic pancreatic adenocarcinoma.
    Parekh, Hiral D.
    Starr, Jason Scott
    Varillas, Jose I.
    Ivey, Alison Marguerite
    Barnes, Isis
    McEwan, Margaret A.
    Trevino, Jose Gilberto
    Cioffi, Jessica
    Hughes, Steven J.
    Grajo, Joseph
    Fan, Z. Hugh
    Allegra, Carmen Joseph
    George, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [8] Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients
    Freed, Ian M.
    Kasi, Anup
    Fateru, Oluwadamilola
    Hu, Mengjia
    Gonzalez, Phasin
    Weatherington, Nyla
    Pathak, Harsh
    Hyter, Stephen
    Sun, Weijing
    Al-Rajabi, Raed
    Baranda, Joaquina
    Hupert, Mateusz L.
    Chalise, Prabhakar
    Godwin, Andrew K.
    Witek, Malgorzata A.
    Soper, Steven A.
    CELLS, 2023, 12 (18)
  • [9] Patients undergoing treatment for pancreatic adenocarcinoma can mount an effective immune response to vaccinations
    Tseng, JF
    Willett, CG
    Fernandez-del Castillo, C
    Ryan, DP
    Clark, JW
    Zhu, AX
    Rattner, DW
    Winkelmann, JL
    Warshaw, AL
    PANCREATOLOGY, 2005, 5 (01) : 67 - 74
  • [10] Patients undergoing treatment for pancreatic adenocarcinoma can mount an effective immune response to vaccinations
    Tseng, JF
    Willett, CG
    Castillo, CFD
    Ryan, DP
    Clark, JW
    Zhu, AX
    Rattner, DW
    Winkelmann, JL
    Warshaw, AL
    GASTROENTEROLOGY, 2002, 123 (01) : 39 - 39